FendX Technologies Inc.

FendX Technologies Inc. A nanotechnology company developing products that reduce the transmission of pathogens.

In partnership with FendX, Dr. Sara Imani, a post-doctoral fellow at McMaster University, has received the Mitacs Innova...
11/25/2025

In partnership with FendX, Dr. Sara Imani, a post-doctoral fellow at McMaster University, has received the Mitacs Innovation Award for advancing an antimicrobial surface coating.

Applied with a brush or roller, this coating provides long-lasting protection by continuously eliminating harmful pathogens.

The award highlights her impactful research and collaboration with FendX to drive public health innovation.

FendX plans to scale up production and finalize the product for market launch in early 2027.

LEARN MORE: https://www.eng.mcmaster.ca/mech/news/postdoctoral-fellow-sara-imani-honoured-with-mitacs-innovation-award/

FendX Technologies has signed an MOU with Aquaox to formulate eco-friendly pathogen-eliminating agents for FendX to deve...
11/18/2025

FendX Technologies has signed an MOU with Aquaox to formulate eco-friendly pathogen-eliminating agents for FendX to develop new disinfectant products, expanding FendX’s pipeline and IP portfolio.

NEWS RELEASE: https://fendxtech.com/news/

CSE: FNDX | OTCQB: FDXTF | FSE: E8D

A provisional patent application was filed with USPTO for a novel medical catheter coating designed to reduce microbial ...
08/26/2025

A provisional patent application was filed with USPTO for a novel medical catheter coating designed to reduce microbial growth and improve patient comfort during insertion. This innovation will join FendX Technologies’ expanding portfolio of hygiene-related technologies aimed at lowering infection risks.

NEWS RELEASE: https://fendxtech.com/news/

CSE: FNDX | OTCQB: FDXTF | FSE: E8D

Provisional patent for an AI-powered app to detect pathogens in real time using a mobile device has been filed by FendX ...
08/20/2025

Provisional patent for an AI-powered app to detect pathogens in real time using a mobile device has been filed by FendX CEO Dr. Carolyn Myers.

NEWS RELEASE: https://fendxtech.com/news/

CSE: FNDX | OTCQB: FDXTF | FSE: E8D

Address

701 W. Georgia Street, Suite 1500
Oakville, ON
L7Y1C6

Website

Alerts

Be the first to know and let us send you an email when FendX Technologies Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to FendX Technologies Inc.:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category